Carol J. Burt Joins IQVIA Board of Directors
22 February 2019 - 12:00AM
Business Wire
IQVIA™ (NYSE:IQV) today announced the appointment of Carol
J. Burt to its board of directors, effective today. A principal of
private investment firm Burt-Hilliard Investments for more than a
decade, Burt is a former executive officer of WellPoint, Inc. (now
Anthem, Inc.), lastly as Senior Vice President, Corporate Finance
and Development, and previously served as Senior Vice President and
Treasurer of American Medical Response. Burt also serves on the
operating council and as a senior advisor to Consonance Capital
Partners.
“We are pleased that Carol has agreed to be a member of our
board,” said Ari Bousbib, chairman and CEO, IQVIA. “In addition to
her deep finance and investment experience, she has a proven track
record of corporate board participation and governance within the
life sciences industry.”
Burt currently serves on the board of directors of ResMed Inc.
and WellDyneRx, LLC. She previously served on the boards of
directors of Envision Healthcare, WellCare Health Plans, Inc.,
Vanguard Health Systems, Inc., and Transitional Hospitals
Corporation. She’s an active member of Women Corporate Directors
and recently served as Chair of the Fortune 1000 Working Group for
the Women’s Leadership Foundation of Colorado.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions and contract research services to
the life sciences industry. Formed through the merger of IMS Health
and Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
Click here to subscribe to Mobile Alerts for IQVIA.
IQVIAFIN
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190221005210/en/
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com)+1.484.567.6732
Andrew Markwick, IQVIA Investor Relations
(andrew.markwick@iqvia.com)+1.973.257.7144
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024